|
[829] Gottlieb, Scott, 2003. US drug sales continue to rise. BMJ , 326, 518. [830] Gottlieb, Scott, 2002. Drug companies maintain 'astounding' profits, BMJ , 324, 1054. [831] Kjaergard, Lise L. and Als-Nielsen, Bodily 2002. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ , 325, 249–252. [832] Eaton, Lynn, 2003. Readers want transparency in link between doctors and drug firms. BMJ , 326, 1352. [833] Mayor, Susan, 2002. Researchers claim clinical trials are reported with misleading statistics. BMJ , 324, 1353. [834] JAMA , 2003, 389, 454–465, quoted by Hopkins Tanne, Janice, 2003. Industry is deeply involved in funding US research. BMJ , 326, 179. [835] Tonks, Alison, 2002. Authors of guidelines have strong links with drugs industry. BMJ , 324, 383. [836] Spurgeon, David, 2002. Doctors accept $50 a time to listen to drug representatives. BMJ , 324, 1113. [837] Gottlieb, Scott, 2003. A fifth of Americans contact their doctor as a result of direct to consumer drug advertising. BMJ , 325, 854. [838] BMJ , 2003. Drug companies want to inform patients. BMJ , 326, 1286. [839] Watson, Rory, 2003. EU health ministers reject proposal for limited direct to consumer advertising. BMJ , 326, 1284. [840] Watson, R., 2006. Cancer group denies company funding will influence its agenda. BMJ , 333, 874. [841] Mayor, Susan, 2002. GMC issues new guidance on clinical research. BMJ , 324, 384. [842] Marwick, Charles, 2002. US tackles drug company gifts to doctors. BMJ , 325, 795. [843] Mosconi, Paola, 2003. Declaration of competing interests is rare in Italian breast cancer associations. BMJ , 327, 344. [844] Herxheimer, A., 2003. Relationships between the pharmaceutical industry and patients' organisations. BMJ , 326, 1208–1210. [845] Hirst, J., 2003. Charities and patient groups should declare interests. BMJ , 326, 1211. [846] Clark, Jocalyn, 2003. A hot flush for Big Pharma. BMJ , 327, 400. [847] Writing Group for the Women's Health Initiative Investigators, 2002. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women. JAMA , 288, 321–333. [848] The Times , 15 December 2006. [849] Moynihan, Ray, 2003. US seniors group attacks pharmaceutical industry 'fronts'. BMJ , 326, 351. [850] Cho, E, and others, 2006. Red meat intake and risk of breast cancer among premenopausal women. Archivesof International Medicine , 166, 2253–2259. — 392 —
|